(Q28324422)

https://api.crossref.org/works/10.1016/S0161-6420(78)35673-6

25 June 2022

2

C A Puliafito

0 references

author name string

W. P. Boger

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A351504

25 June 2022

R. F. Steinert

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A351504

25 June 2022

D. P. Langston

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A351504

full work available at URL

25 June 2022

language of work or name

English

0 references

publication date

March 1978

0 references

https://api.elsevier.com/content/article/PII:S0161642078356736?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(78)35673-6

https://api.elsevier.com/content/article/PII:S0161642078356736?httpAccept=text/plain

25 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(78)35673-6

25 June 2022

0 references

85

0 references

issue

3

0 references

page(s)

259-67

0 references

cites work

Perspectives in adrenergic beta-receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

A comparison of beta adrenergic blocking drugs in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Comparison of cardiac effects of timolol and propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Duration of cardiac effects of timolol and propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Effect of timolol versus propranolol on hypertension and hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Timolol, dose response and duration of action

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2878%2935673-6

7 January 2021

Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension

16

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(78)35673-6

Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution

4 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(78)35673-6

4 April 2023

Identifiers

0 references